Contract research organisation, Xenobiotic Laboratories (XBL), has purchased the Debra Lims solution from Lablogic Systems to manage ADME data at its New Jersey research facility.
'Getting accurate data to our clients quicker and timely is our prime imperative,' said Dennis Heller, XBL's vice-president for pharmaceutical development.
'After seeing the latest version of Debra, which includes a new module to perform protein binding assays and the ability to pool metabolism samples, we realised that now was the time to move forward with Lablogic's solution.
'We are also expanding our capabilities with the addition of QWBA study support in early 2009 and will be using Debra to centralise all WBA study data.' President of XBL, Jinn Wu, added that the company is intending to implement Debra at its facility in China once its ADME and bioanalytical services have been set up in 2009.
The addition of Debra Lims and QWBA study support are examples of how XBL continues to enhance its core service areas in ADME and bioanalysis available to the pharmaceutical, animal health and agrochemical industries.
